Drive Antimicrobial Stewardship by Eliminating False-Positive Blood Cultures
University of Nebraska's Clinical Trial on Eliminating Blood Culture Contamination

  • Event Date:
  • Event Time: 1 p.m. Central

A 3 percent false-positive blood culture rate is currently considered "acceptable." Given a national average of 8 percent positive blood cultures, 35 - 50 percent of these positive cultures are actually false-positive, including those for sepsis. Improving sepsis diagnosis can help hospitals reduce the number of patients exposed to the risks of unnecessary antibiotics and hospitalization. It can also dramatically impact the Triple Aim by improving patient safety, antimicrobial stewardship and quality outcome metrics while reducing hospital costs.

Join us to hear from Mark Rupp, MD, UNMC's Chief of Infectious Diseases, as he shares the impact a blood specimen diversion device had on blood culture testing accuracy. UNMC virtually eliminated blood culture contamination and false-positive blood culture results, demonstrating a 93 percent improvement in testing accuracy. This advancement provided improved sepsis diagnosis and avoidance of antibiotics in patients who clinically did not need them.

Barb DeBaun, RN, MSN, CIC, will facilitate the discussion including the clinical and economic impact of false-positive blood culture results.

What You Will Learn:

  • The extent of the public health challenge associated with the current standards in blood culture testing
  • The improvements achievable in patient safety, antimicrobial stewardship, quality outcome metrics and hospital costs
  • A clinical trial case study demonstrating the impact of new technology, and the achievable new standard in blood culture accuracy


Sponsored by: sponsor logo

« View All Events